Linked Life Data

18946234

Source:http://linkedlifedata.com/resource/pubmed/id/18946234

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-12-1
pubmed:abstractText
During the course of development of montelukast, a cysteinyl leukotriene receptor 1 antagonist, for treatment of seasonal allergic rhinitis, a double-blind, non-inferiority study was carried out to evaluate the efficacy and safety of montelukast 5mg and 10mg compared with pranlukast 450mg, which has a similar mechanism of action.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1323-8930
pubmed:author
pubmed:issnType
Print
pubmed:volume
57
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
383-90
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis.
pubmed:affiliation
Department of Otorhinolaryngology, Nippon Medical School Hospital, Tokyo, Japan. ent-kimi@nms.ac.jp
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Multicenter Study